Complement activation in severe Plasmodium falciparum malaria

Clinical Immunology and Immunopathology

Volumn 85, Issue 2, 1997, Pages 166-171

  Wenisch, Christoph ^a   Spitzauer, Susanne ^b   Florris Linau, Ken ^c   Rumpold, Helmut ^a   Vannaphan, Suparp ^a   Parschalk, Bernhard ^a   Graninger, Wolfgang ^a   Looareesuwan, Sornchai ^a  

^a Wilheminenspital   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; ARTESUNATE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT MEMBRANE ATTACK COMPLEX; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT SYSTEM; DISEASE SEVERITY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALARIA; MALE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 0030778705     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4417     Document Type: Article

References (42)

1. Ward, P. A., Sterzel, R. B., Lucia, H. L., Campbell, G. H., and Jack, R. M., Complement does not facilitate plasmodial infections. J. Immunol. 126, 1826-1828, 1980.
2. Dulaney, A. D., Priest, J. B., Almeda, M. L., and Parker, B., The complément content of human sera with special reference to malaria. J. Clin. Invest. 27, 320, 1948.
3. Rosenberg, E. B., Strickland, G. T., Yang, S. L., and Whalen, G. E., IgM antibodies to red cells and autoimmune anemia in patients with malaria. Am. J. Trop. Hyg. 22, 146, 1973.
4. Greenwood, B. M., and Bruton, M. J., Complement activation in children with acute malaria. Clin. Exp. Immunol. 18, 267,1974.
5. Adam, C., Geniteau, M., Gougerot-Pocidalo, M., Verroust, P., Lebras, J., Gilbert, C., and Morel-Maroger, L., Cryoglobulins, circulating immune complexes, and complement activation in cerebral malaria. Infect. Immun. 31, 530, 1981.
6. Neva, F. A., Howard, W. A., Glew, R. H., Krotoski, W. A., Gam, A. A., Collins, W. E., Atkinson, J. P., and Frank, M. M., Relationship of serum complement levels to events of the malarial paroxysm. J. Clin. Invest. 54, 451-460, 1974.
7. Srichaikul, T., Puwasatten, P., Karnjanajetanee, J., and Bokish, V. A., Complement changes and disseminated intravascular co-agulation in Plasmodium falciparum malaria. Lancet i, 770, 1975.
8. Goundis, D., and Reid, K. B., Properdin, the terminal complement components, thrombospondin and the circumsporozoite protein of malaria parasites contain similar sequence motifs. Nature 335, 82-85, 1988.
9. Williamson, W. A., Damisah, M., and Greenwood, B. M., Hypocomplementaemia in children with Plasmodium falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 676-677, 1978.
10. Kern, P., Hemmer, G. J., Van Damme, J., Grass, H. J., and Dietrich, M., Am. J. Med. 87, 139-143, 1989.
11. Kern, P., Hemmer, G. J., Gallati, H., Neifer, S., Kremsner, P., Dietrich, M., and Porzsolt, F., Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria. J. Infect. Dis. 166, 930-934, 1992.
12. Grau, G. E., Taylor, T. E., Molyneux, M. E., Wirima, J. J., Vassalli, P., Hommel, M., and Lambert, P. H., Tumor necrosis factor and disease severity in children with falciparum malaria. N. Engl. J. Med. 320, 1586-1591, 1989.
13. Kwiatkowski, D., et al., TNF concentration in fatal cerebral, nonfatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336, 1201-1204, 1990.
14. Grau, G. E., Tumor necrosis factor/cachectin as an essential mediator in murine cerebral malaria. Science 237, 1210-1212, 1987.
15. Wenisch, C., Varijanonta, S., Looareesuwan, S., Graninger, W., Pichler, R., and Wernsdorfer, W., Soluble intercellular adhesion molecule-1, soluble E-selectin, and soluble tumor necrosis factor 55kD in Plasmodium falciparum malaria. Clin. Immunol. Immunopathol. 71, 344-348, 1994.
16. Wenisch, C., Parschalk, B., Burgmann, H., Looareesuwan, S., and Graninger, W., Decreased serum levels of TGF-beta in patients with acute Plasmodium falciparum Malaria. J. Clin. Immunol. 15, 69-73, 1995.
17. Wenisch, C., Parschalk, B., Narzt, E., Looareesuwan, S., and Graninger, W., Elevated serum levels of IL-10 and IFN-γ in patients with acute Plasmodium falciparum malaria. Clin. Immunol. Immunopathol. 74, 115-117, 1995.
18. Sundsmo, J. S., and Wood, L. M., Activated factor B (Bb) of the alternative pathway of complement activation cleaves and activates plasminogen. J. Immunol. 127, 877-880, 1981.
19. Johnson, R. B., The complement system in host defense and inflammation: The cutting edges of a double-edged sword. Pediatr. Infect. Dis. J. 12, 933-941, 1993.
20. Kojima, H., Ohi, H., Seki, M., and Hatano, M., Changes in complement breakdown products and terminal complement complex in patients with acute glomerulonephritis. Nippon Jinzo Gakkhi Shi 31, 925-931, 1989.
21. Ade-Serrano, M. A., Ejezie, G. C., and Kassim, O. O., Correlation of Plasmodium falciparum gametocytemia with complement component titers in rural Nigerian school children. J. Clin. Microbiol. 13, 195-198, 1981.
22. Srichaikul, T., Puwasatien, P., Puwasatien, P., Karnjanajetanee, J., and Bokisch, V. A., Complement changes and disseminated intravascular coagulation in Plasmodium falciparum malaria. Lancet 770-772, 1975.
23. Phanuphak, P., Hanvanic, M., Sakulramrung, R., Moollaor, P., Sitprija, V., and Phanthumkosol, D., Complement changes in falciparum malaria infection. Clin. Exp. Immunol. 59,571-576, 1985.
24. McGregor, I. A., Turner, M. W., Williams, K., and Hall, P., Soluble antigens in the blood of African patients with severe Plasmodium falciparum malaria. Lancet i, 881, 1968.
25. Houba, V., and Williams, A. I. O., Soluble malaria antigens of P. falciparum in Nigerians. II. Immunochemical studies. Afr. J. Med. Sei. 3, 309, 1972.
26. Topley, E., Knight, R., and Woodruff, A. W., The direct antiglobulin test and immunoconglutinin titres in patients with malaria. Trans. R. Soc. Trop. Med. Hyg. 67, 51, 1973.
27. Trubowitz, S., and Masek, B., Plasmodium falciparum: Phagocytosis by polymorphonuclear leukocytes. Science 162, 273-274, 1968.
28. Tsieh, S., and Chakrabarti, C., Schizonts, merozoites and phagocytosis in falciparum malaria. Ann. Clin. Lab. Sei. 15,465-467, 1985.
29. Kumaratilake, L. M., Ferrante, A., and Rzepczyk, C. M., Tumor necrosis factor enhances neutrophil-mediated killing of Plasmadium falciparum-malaria. Infect. Immun. 58, 788-793, 1990.
30. Kumaratilake, L. M., Ferrante, A., and Rzepczyk, C. M., The role of T lymphocytes in immunity to Plasmodium falciparum: Enhancement of neutrophil-mediated parasite killing by lymphotoxin and IFN-gamma: Comparisons with tumor necrosis factor effects. J. Immunol. 146, 762-767, 1991.
31. Salmon, D., Vilde, J. L., Andrieu, B., Simonovic, R., and Lebras, J., Role of immune serum and complement in stimulation of the metabolic burst of human neutrophils by plasmodium falciparum. Infect. Immun. 51, 801-806, 1986.
32. Kumaratilake, L. M., Ferrante, A., Jaeger, T., and Rzepczyk, C. M., Effects of cytokines, complement, and antibody on the neutrophil respiratory burst and phagocytic response to plasmodium falciparum merozoites. Infect. Immun. 60, 3731-3738, 1992.
33. Hunter, K W., Jr., Winkelstein, J. A., and Simpson, T. W., Serum opsonic activity in rodent malaria: Functional and immuno-chemical characteristics in vitro. J. Immunol. 123, 2582-2587, 1979.
34. Ehlenberger, A. G., and Nussenzweig, V., The role of membrance receptors for C3b and C3d in phagocytosis. J. Exp. Med. 145, 357-371, 1977.
35. Griffin, F. M., Jr., Biological amplifications systems in immunology: Opsonization. In "Comprehensive Immunology" (R. A. Good and S. B. Day, Eds.), pp. 85-114, Plenum, New York, 1977.
36. Ganguly, N. K., Chandanani, R. E., Mahajan, R. C., Sharma, S., and Vasudeva, V., Immunoglobulins and C3 levels in Plasmodium vivax infection and their relationship to haemagglutination antibody titres. Ind. J. Med. Res. 71, 505, 1980.
37. Lin, R. Y., Astiz, M. E., Saxon, J. C., Saha, D. C., and Rackow, E. C., Alterations in C3, C4, factor B, and related metabolites in septic shock. Clin. Immunol. Immunopathol. 69,136-142,1993.
38. Brandtzaeg, P., Mollnes, T. E., and Kierulf, P., Complement activation and endotoxin levels in systemic meningococcal disease. J. Infect. Dis. 160, 58-65, 1989.
39. Lucchesi, B. R., Complement, neutrophils and free radicals: Mediators of reperfusion injury. Drug Res. 44, 420-432, 1994.
40. Pangburn, M. K., and Müller-Eberhard, H. J., The alternative pathway of complement. In "Complement" (H. J. Müller-Eberhard and P. A. Miescher, Eds.), p. 185, Springer Verlag, Berlin, 1984.
41. Fishelson, Z., and Müller-Eberhard, H. J., Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb. J. Immunol. 132, 1425-1431, 1984.
42. Gotze, O., Bianco, C., and Cohn, Z. A., The induction of macrophage spreading by factor B of the properdin system. J. Exp. Med. 149, 372-376, 1979.